RedHill Biopharma Ltd.
RDHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553846
In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding RedHill Biopharma Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 55 | 1 | 61 | +7 |
| Shares | 7.13M | 1.00K | 5.33M | −1.80M (−25.2%) |
| Value | $49.1M | $7.00K | $24.5M | −$24.6M (−50.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held RedHill Biopharma Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Envestnet Asset Management Inc | 77,243 | $354.0K | 0.00% |
| Group One Trading, L.P. | 67,532 | $309.0K | 0.01% |
| Citadel Advisors LLC | 39,927 | $183.0K | 0.00% |
| Eaton Vance Management | 38,417 | $176.0K | 0.00% |
| Ancora Advisors, LLC | 37,500 | $172.0K | 0.00% |
| Capital Asset Advisory Services LLC | 28,888 | $132.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 20,077 | $92.0K | 0.00% |
| Virtu Financial LLC | 19,217 | $88.0K | 0.01% |
| Phoenix Holdings Ltd. | 16,578 | $75.0K | 0.00% |
| HRT Financial LP | 12,659 | $57.0K | 0.00% |
| Commonwealth Equity Services, LLC | 11,687 | $53.0K | 0.00% |
| Proequities, Inc. | 3,681 | $17.0K | 0.00% |
| Cutler Group LP | 3,800 | $17.0K | 0.00% |
| Belvedere Trading LLC | 885 | $4.00K | 0.00% |
| US Bancorp | 702 | $3.00K | 0.00% |
| Koshinski Asset Management, Inc. | 345 | $1.58K | 0.00% |
| First Horizon Advisors, Inc. | 66 | $0 | 0.00% |
| Parallel Advisors, LLC | 95 | $0 | 0.00% |
Sold out (11)
Institutions that held RedHill Biopharma Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| DAFNA Capital Management LLC | 455,933 | $3.14M |
| Sabby Management, LLC | 340,440 | $2.34M |
| ACT Capital Management, LLC | 140,000 | $964.0K |
| Sowell Financial Services LLC | 92,672 | $638.0K |
| Jefferies Group LLC | 40,000 | $275.2K |
| Renaissance Technologies LLC | 19,879 | $137.0K |
| Jump Financial, LLC | 14,700 | $101.0K |
| Quadrant Capital Group LLC | 1,942 | $13.0K |
| Corbenic Partners LLC | 100 | $1.00K |
| Spire Wealth Management | 200 | $1.00K |
| Lindbrook Capital, LLC | 9 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held RedHill Biopharma Ltd. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Elmwood Wealth Management, Inc. | 1,000 | $7.00K |